[Google Scholar] 41.Lands LC, Grey VL, Smountas AA
No drug interactions with SSRIs or SNRIs
However, because semaglutide was found to cause stomach paralysis in some users at the end of 2023, there is now a shortage of the drug across the country
Additionally, Semaglutide has FDA approval for reducing major cardiovascular events , such as heart attacks and strokes, in certain populations a benefit that is still being studied for tirzepatide
However, the mechanism behind this effect is unclear since other studies have suggested that NT alone promotes glutamatergic signaling (Ferraro et al., 2011)
The bundle pricing (from $99/mo on the 12-month plan) and microdosing option make it a distinctly different play than the three programs above